Veikko Salomaa

Year of birth: 1950
Official title: Research Professor (emeritus)
Tel. +358 40 504 1649
E-mail: [email protected]

Expertise

  • Cardiovascular epidemiology
  • “Omics”, i.e., microbiomics, metabolomics, genomics
  • Biomarkers of cardiovascular disease

Education

  • 1994, Assoc. Prof., Department of Public Health, University of Helsinki
  • 1988, PhD, University of Helsinki
  • 1984, Specialist in internal medicine, University of Helsinki
  • 1976, MD, University of Helsinki

Professional background

  • 2005–, Research Professor in THL, emeritus since 2017
  • 1995–2014, Chief Physician, Head of Unit in THL-KTL
  • 1991–2 and 1997–8, Visiting Scientist, University of North Carolina, Chapel Hill, USA
  • 1982–84, Resident Physician, 2nd Department of Medicine, University Hospital of Helsinki

Language skills

  • Finnish (native)
  • English (excellent)
  • Swedish (good)
  • German (fair)

Current projects

Previous projects

  • FINAMI
  • Finnish Cardiovascular Disease Register

Affiliations

Member of the nucleus, Working Group of Preventive Cardiology, Finnish Cardiac Society

Publications and research

Scientific research articles

Over 800 peer-reviewed scientific publications in English (as of 06.01.2023). A few most recent ones are listed below.

  • Yang Liu, Shu Mei Teo, Guillaume Meric, Howard H.F. Tang, Qiyun Zhu, Jon G Sanders, Yoshiki Vazquez-Baeza, Karin Verspoor, Ville A Vartiainen, Pekka Jousilahti, Leo Lahti, Teemu Niiranen, Aki S. Havulinna, Rob Knight, Veikko Salomaa, Michael Inouye. The gut microbiome is a significant risk factor for future chronic lung disease. J Allergy Clin Immunol. 2022 Dec 29:S0091-6749(22)02577-5.
  • Yang Liu, Guillaume Meric, Aki S. Havulinna, Shu Mei Teo, Fredrik Åberg, Matti Ruuskanen, Jon Sanders, Qiyun Zhu, Anupriya Tripathi, Karin Verspoor, Susan Cheng, Mohit Jain, Pekka Jousilahti, Yoshiki Vázquez-Baeza, Rohit Loomba, Leo Lahti, Teemu Niiranen, Veikko Salomaa, Rob Knight, Michael Inouye. Early prediction of incident liver disease using conventional risk factors and gut microbiome-augmented gradient boosting. Cell Metab. 2022 May 3;34(5):719-730.e4.
  • Matti O. Ruuskanen, Pande P. Erawijantari, Aki S. Havulinna, Yang Liu, Guillaume Méric, Jaakko Tuomilehto, Michael Inouye, Pekka Jousilahti, Veikko Salomaa, Mohit Jain, Rob Knight, Leo Lahti, Teemu J. Niiranen. Gut microbiome composition is predictive of incident type 2 diabetes in a population cohort of 5 572 Finnish adults. Diabetes Care. 2022 Apr 1;45(4):811-818.
  • Youwen Qin, Aki S. Havulinna, Yang Liu, Pekka Jousilahti, Scott C. Ritchie, Alex Tokolyi, Jon G. Sanders, Liisa Valsta, Marta Brożyńska, Qiyun Zhu, Anupriya Tripathi, Yoshiki Vazquez-Baeza, Rohit Loomba, Susan Cheng, Mohit Jain, Teemu Niiranen, Leo Lahti, Rob Knight, Veikko Salomaa, Michael Inouye, Guillaume Méric. Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort. Nat Genet. 2022 Feb;54(2):134-142.
  • Kari K. Koponen, Aaro Salosensaari, Matti O. Ruuskanen, Aki S. Havulinna, Satu Männistö, Pekka Jousilahti, Joonatan Palmu, Rodolfo Salido, Karenina Sanders, Caitriona Brennan, Gregory C. Humphrey, Jon G. Sanders, Guillaume Meric, Susan Cheng, Michael Inouye, Mohit Jain, Teemu J. Niiranen, Liisa M. Valsta, Rob Knight, Veikko V. Salomaa. Associations of healthy food choices with gut microbiota profiles. Am J Clin Nutr 2021 Aug 2;114(2):605-616.

Updated: